跳至主要内容
临床试验/NL-OMON37296
NL-OMON37296尚未招募不适用

INX* Reflux Management System Clinical Study - LINX* Reflux Management System Clinical Study

Torax medical, Inc.0 个研究点目标入组 10 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Age * 19 years - * 75 years
  • Suitable surgical candidate
  • Patient requires daily PPI or other anti-reflux therapy
  • Total distal Ambulatory Esophageal pH must be * 4.5% of the time * pH4
  • GERD symptoms in absence of anti-reflux therapy
  • Subject has signed an ICF

排除标准

  • The procedure is an emergency procedure
  • Patient is currently being treated with another investigational drug or investigational device
  • Prior gastric esophageal surgery
  • Any previous endoscopic anti-reflux intervention for GERD and /or previous endoscopic intervention for treatment of Barret's esophagus
  • Suspected or confirmed esophageal or gastric cancer
  • Hiatal hernia > 3 cm
  • Esophageal motility less than 35 mmHg peristaltic amplitude on wet swallows or < 70% (propulsive) peristaltic sequences
  • Esophagitis grade C-D
  • Symptoms of dysphagia more than once a week within the last 3 months
  • Patient diagnosed with scleroderma or achalasia, Nutcracker esophagus
  • Gross esophageal anatomic abnormalities or esophgeal stricture
  • Patient is pregnant or nursing or plans to become pregnant
  • Patient has Barret esophagus
  • Allergies to titanium, stainless steel, nickel or ferrous materials
  • Diagnosed psychiatric disorders

研究者

发起方
Torax medical, Inc.

相似试验